TYROSINE KINASES ARE INVOLVED WITH THE EXPRESSION OF INDUCIBLE NITRIC-OXIDE SYNTHASE IN HUMAN ARTICULAR CHONDROCYTES

被引:49
作者
GENG, Y
MAIER, R
LOTZ, M
机构
[1] UNIV CALIF SAN DIEGO, SCH MED, SAM & ROSE STEIN INST RES AGING, LA JOLLA, CA 92093 USA
[2] UNIV CALIF SAN DIEGO, SCH MED, DEPT MED, LA JOLLA, CA 92093 USA
关键词
D O I
10.1002/jcp.1041630315
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
The present study characterizes mechanisms involved with the induction of nitric oxide (NO) production, nitric oxide synthase (NOS) enzymatic activity and mRNA expression in human articular chondrocytes. Activation of chondrocytes with lipopolysaccharide (FPS) or IL-l resulted in time- and dose-dependent increases in iNOS mRNA followed by increased NOS enzymatic activity and NO release. The protein tyrosine kinase (PTK) inhibitors herbimycin A or genistein reduced IL-l or LPS-induced NO release and NOS enzymatic activity. This was associated with inhibition of iNOS mRNA expression as determined by reverse transcription-polymerase chain reaction (RT-PCR) and in situ hybridization. In contrast, inhibitors of protein kinase C (PKC) or protein kinase A (PKA) did not affect these responses. These results were confirmed in experiments with second messenger agonists where neither activation of PKC, nor increases in cyclic adenosine monophosphate (cAMP) or increased intracellular calcium levels were associated with the induction of iNOS mRNA or NO release. These results suggest that PKC, PKA and calcium-dependent signals are not required or sufficient for the stimulation of NO production. However, NO production is dependent on tyrosine kinases due to their role in the expression of iNOS mRNA. (C) 1995 Wiley-Liss, Inc.
引用
收藏
页码:545 / 554
页数:10
相关论文
共 62 条
  • [1] Akiyama T., Ogawara H., Use and specificity of genistein as inhibitor of protein‐tyrosine kinases, Methods Enzymol., 201, pp. 362-370, (1991)
  • [2] Bogdan C., Vodovotz Y., Paik J., Xie Q.W., Nathan C., Traces of bacterial lipopolysaccharide suppress IFN‐gamma‐in‐duced nitric oxide synthase gene expression in primary mouse macrophages, J. Immunol., 151, pp. 3091-3309, (1993)
  • [3] Bredt D.S., Snyder S.H., Nitric oxide, a novel neuronal messenger, Neuron, 8, pp. 3-11, (1992)
  • [4] Bredt D.S., Hwang P.M., Glatt C.E., Lowenstein C., Reed R.R., Snyder S.H., Cloned and expressed nitric oxide synthase structurally resembles cytochrome P‐450 reductase, Nature, 351, pp. 714-718, (1991)
  • [5] Bredt D.S., Ferris C.D., Snyder S.H., Nitric oxide synthase regulatory sites. Phosphorylation by cyclic AMP‐dependent protein kinase, protein kinase C, and calcium/calmodulin protein kinase
  • [6] identificaiton of flavin and calmodulin binding sites, J. Biol. Chem., 267, pp. 10976-10981, (1992)
  • [7] Brune B., Lapetina E.G., Phosphorylation of nitric oxide synthase by protein kinase A, Biochem. Biophys. Res. Commun., 181, pp. 921-926, (1991)
  • [8] Bulut V., Severn A., Liew F.Y., Nitric oxide production by murine macrophages is inhibited by prolonged elevation of cyclic AMP, Biochem. Biophys. Res. Commun., 195, pp. 1134-1138, (1993)
  • [9] Busse R., Mulsch A., Induction of nitric oxide synthase by cytokines in vascular smooth muscle cells, FEBS Lett., 275, pp. 87-90, (1990)
  • [10] Casnellie J.E., Protein kinase inhibitors: Probes for the functions of protein phosphorylation, Adv. Pharmacol., 22, pp. 167-205, (1991)